Synthesis, Characterization, and Antibacterial Activity of Novel Mutual Non-Steroidal Anti-inflammatory Prodrugs

  • Banaz mohammed hamadameen Department of Pharmaceutical chemistry, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq
  • Dana M. Hamad Ameen Department of Pharmaceutical chemistry, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq
Keywords: NSAIDs, antibacterial, prodrug, acetamide.

Abstract

Non steroidal anti-inflammatory drugs (NSAIDs) are among the most used analgesic and anti-inflammatory drugs. However inhibition of cyclooxygenase1 and acidic groups such as carboxylic groups in most NSAIDs cause gastrointestinal (GI) side effects. Therefore masking the acidic groups till it pass through the GI tract will decrease the direct GI side effects and because N-(2,6-dimethylphenyl)-acetamide 1 also has anti-inflammatory activity so the synthesized ester prodrugs might act as mutual prodrugs. Moreover, because of emerging of new strains of bacteria and resistance of bacteria to the available antibacterial agents, new antibacterial agents are needed. The NSAIDs have antibacterial activity and N-(2,6-dimethylphenyl) acetamide 1 also has antibacterial activity so binding of these molecules with each other might give more potent antibacterial agent. 2-Chloro-N-(2,6-dimethyl phenyl) acetamide 1 was utilized to synthesize ester prodrug of various NSAIDs 2a-f. The 2-Chloro-N-(2,6-dimethylphenyl)-acetamide 1 undergo substitution reaction at α position  with various sodium carboxylate of NSAIDs 2a-f in DMSO. The constitution of the newly synthesized ester prodrugs of NSAIDs 3a-f had been confirmed on the basis of their IR, ¹H and ¹³C-NMR spectral data. All the synthesized ester prodrugs 3a-f were screened for their in vitro antibacterial activities against Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922 however, their antibacterial activity decreased compared with their starting 1 and 2a-f.

References

ABDULHADI, S. L., QASIR, A. J. & RAZZAK, N. A. A. 2013. Synthesis of new conjugates of some NSAIDs with sulfonamide as possible mutual prodrugs using tyrosine spacer for colon targeted drug delivery. Iraqi Journal of Pharmaceutical Sciences (P-ISSN: 1683-3597, E-ISSN: 2521-3512), 22, 22-29.
AHMED, E. F., EL-BAKY, R. M. A., AHMED, A. B. F., WALY, N. G. & GAD, G. F. M. 2017. Antibacterial activity of some non-steroidal anti-inflammatory drugs against bacteria causing urinary tract infection. Am. J. Infect. Dis. Microbiol, 5, 66-73.
AL-JANABI, A. A. H. S. 2010. In vitro antibacterial activity of Ibuprofen and acetaminophen. Journal of global infectious diseases, 2, 105.
AMIR, M., AKHTER, M. & SOMAKALA, K. 2016. Synthesis, In Vitro and In Vivo Evaluation of the N-Ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug. Indian J. Chem. B, 55, 989-998.
ASHRAF, Z., ALAMGEER, M. K., HASSAN, M., ABDULLAH, S., WAHEED, M., AHSAN, H. & KIM, S. J. 2016. Flurbiprofen–antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling. Drug design, development and therapy, 10, 2401.
BÄCK, M., YIN, L. & INGELSSON, E. 2011. Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib. European heart journal, 33, 1928-1933.
BJARNASON, I., SCARPIGNATO, C., HOLMGREN, E., OLSZEWSKI, M., RAINSFORD, K. D. & LANAS, A. 2018. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology, 154, 500-514.
CHAN, E. W. L., YEE, Z. Y., RAJA, I. & YAP, J. K. Y. 2017. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus. Journal of global antimicrobial resistance, 10, 70-74.
CHEN, I.-L., CHEN, J.-J., LIN, Y.-C., PENG, C.-T., JUANG, S.-H. & WANG, T.-C. 2013. Synthesis and antiproliferative activities of N-(naphthalen-2-yl) acetamide and N-(substituted phenyl) acetamide bearing quinolin-2 (1H)-one and 3, 4-dihydroquinolin-2 (1H)-one derivatives. European journal of medicinal chemistry, 59, 227-234.
CHUNG, P. Y., NAVARATNAM, P. & CHUNG, L. Y. 2011. Synergistic antimicrobial activity between pentacyclic triterpenoids and antibiotics against Staphylococcus aureus strains. Annals of Clinical Microbiology and Antimicrobials, 10, 25.
DATAR, P. & SHENDGE, T. 2015. Design, synthesis and stability studies of mutual prodrugs of NSAID’s. Chem Informatics, 1, 1-7.
DE CASTRO BARBOSA, M. L., DE ALBUQUERQUE MELO, G. M., DA SILVA, Y. K. C., DE OLIVEIRA LOPES, R., DE SOUZA, E. T., DE QUEIROZ, A. C., SMANIOTTO, S., ALEXANDRE-MOREIRA, M. S., BARREIRO, E. J. & LIMA, L. M. 2009. Synthesis and pharmacological evaluation of N-phenyl-acetamide sulfonamides designed as novel non-hepatotoxic analgesic candidates. European Journal of Medicinal Chemistry, 44, 3612-3620.
ERTAN, T., YILDIZ, I., OZKAN, S., TEMIZ-ARPACI, O., KAYNAK, F., YALCIN, I., AKI-SENER, E. & ABBASOGLU, U. 2007. Synthesis and biological evaluation of new N-(2-hydroxy-4 (or 5)-nitro/aminophenyl) benzamides and phenylacetamides as antimicrobial agents. Bioorganic & medicinal chemistry, 15, 2032-2044.
GALANAKIS, D., KOUROUNAKIS, A. P., TSIAKITZIS, K. C., DOULGKERIS, C., REKKA, E. A., GAVALAS, A., KRAVARITOU, C., CHARITOS, C. & KOUROUNAKIS, P. N. 2004. Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity. Bioorganic & medicinal chemistry letters, 14, 3639-3643.
GALVEZ-LLOMPART, M., M GINER, R., C RECIO, M., CANDELETTI, S. & GARCIA-DOMENECH, R. 2010. Application of molecular topology to the search of novel NSAIDs: Experimental validation of activity. Lett Drug Des Discov, 7, 438-445.
GUAN, L.-P., LIU, B.-Y., QUAN, Y.-C., YANG, L.-Y., ZHEN, X.-H. & WANG, S.-H. 2016. Synthesis and evaluation of phenyliminoindolin-containing phenylacetamide derivatives with the antidepressant and anticonvulsant effects. Medicinal Chemistry, 12, 786-794.
HAMAD, A. N., AHMED, S. M., JAWHAR, Z. H., HAMAD, D. H. & SALIH, K. M. 2017. Synthetic Approaches and Pharmacological Evaluation of Some New Acetamide Derivatives and 5-Benzylidene-2-(2, 6-dimethyl-phenylimino)-thiazolidin-4-ones. ZANCO Journal of Pure and Applied Sciences, 29, 13-24.
HAMAD, A. N., BRIEM, R. R. & NOORADDIN, S. M. 2016. Synthesis, structure elucidation and antibacterial screening of some new 1, 3-imidazolinone derivatives using micro broth dilution assay. ZANCO Journal of Pure and Applied Sciences, 27, 19-30.
HUANG, Z., VELÁZQUEZ, C. A., ABDELLATIF, K. R., CHOWDHURY, M. A., REISZ, J. A., DUMOND, J. F., KING, S. B. & KNAUS, E. E. 2011. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies. Journal of medicinal chemistry, 54, 1356-1364.
JAMKHANDI, C. & DISOUZA, J. I. 2012. Synthesis and antimicrobial evaluation of 2-(1H-1, 2, 3-Benzotriazol-1-yl)-N-phenylacetamide derivatives. Research J. Pharm. and Tech, 5, 1072-75.
KALYANASUNDARAM, M. & MATHEW, N. 2006. N, N-diethyl phenylacetamide (DEPA): a safe and effective repellent for personal protection against hematophagous arthropods. Journal of medical entomology, 43, 518-525.
KATKE, S., AMRUTKAR, S., BHOR, R. & KHAIRNAR, M. 2011. Synthesis of biologically active 2-chloro-N-alkyl/aryl acetamide derivatives. International Journal of Pharma Sciences and Research, 2, 148-156.
LAINE, L. The gastrointestinal effects of nonselective NSAIDs and COX-2–selective inhibitors. Seminars in arthritis and rheumatism, 2002. Elsevier, 25-32.
MAKHIJA, D., SOMANI, R. & CHAVAN, A. 2013. Synthesis and pharmacological evaluation of antiinflammatory mutual amide prodrugs. Indian journal of pharmaceutical sciences, 75, 353.
MARNETT, L. J. 2009. Mechanisms of cyclooxygenase-2 inhibition and cardiovascular side effects—The plot thickens. Cancer prevention research, 2, 288-290.
MOLLA, Y., NEDI, T., TADESSE, G., ALEMAYEHU, H. & SHIBESHI, W. 2016. Evaluation of the in vitro antibacterial activity of the solvent fractions of the leaves of Rhamnus prinoides L’Herit (Rhamnaceae) against pathogenic bacteria. BMC complementary and alternative medicine, 16, 287.
ÖZKAY, Y., IŞıKDAĞ, İ., İNCESU, Z. & AKALıN, G. 2010. Synthesis of 2-substituted-N-[4-(1-methyl-4, 5-diphenyl-1H-imidazole-2-yl) phenyl] acetamide derivatives and evaluation of their anticancer activity. European journal of medicinal chemistry, 45, 3320-3328.
PACHECO, D. J., TRILLERAS, J., QUIROGA, J., GUTIÉRREZ, J., PRENT, L., COAVAS, T., MARÍN, J. C. & DELGADO, G. 2013. N-(4-((E)-3-Arylacryloyl) phenyl) acetamide Derivatives and their Antileishmanial Activity. Journal of the Brazilian Chemical Society, 24, 1685-1690.
PAWAR, C. D., SARKATE, A. P., KARNIK, K. S. & SHINDE, D. B. 2017. Synthesis and evaluation of [N-(Substituted phenyl)-2-(3-substituted) sulfamoyl) phenyl)] acetamide derivatives as anticancer agents. Egyptian Journal of Basic and Applied Sciences, 4, 310-314.
SAWANT, R. & KAWADE, D. 2011. Synthesis and biological evaluation of some novel 2-phenyl benzimidazole-1-acetamide derivatives as potential anthelmintic agents. Acta Pharmaceutica, 61, 353-361.
SOYER, Z., KıLıÇ, F. S., EROL, K. & PABUÇCUOĞLU, V. 2004. Synthesis and anticonvulsant activity of some ω-(1H-imidazol-1-yl)-N-phenylacetamide and propionamide derivatives. Il Farmaco, 59, 595-600.
TARIKOGULLARI, A. H., FATMA, S. K., EROL, K. & PABUCCUOGLU, V. 2010. Synthesis and anticonvulsant activity of some alkanamide derivatives. Arzneimittelforschung, 60, 593-598.
TAYE, B., GIDAY, M., ANIMUT, A. & SEID, J. 2011. Antibacterial activities of selected medicinal plants in traditional treatment of human wounds in Ethiopia. Asian Pacific Journal of Tropical Biomedicine, 1, 370-375.
YADAV, S., LIM, S. M., RAMASAMY, K., VASUDEVAN, M., SHAH, S. A. A., MATHUR, A. & NARASIMHAN, B. 2018. Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1 H-benzo [d] imidazol-2-ylthio)-N-substituted acetamides. Chemistry Central Journal, 12, 66.
YIN, Z., WANG, Y., WHITTELL, L. R., JERGIC, S., LIU, M., HARRY, E., DIXON, N. E., KELSO, M. J., BECK, J. L. & OAKLEY, A. J. 2014. DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chemistry & biology, 21, 481-487.
ZWOLINSKA-WCISLO, M., KRZYSIEK-MACZKA, G., PTAK-BELOWSKA, A., KARCZEWSKA, E., PAJDO, R., SLIWOWSKI, Z., URBANCZYK, K., DROZDOWICZ, D., KONTUREK, S. & PAWLIK, W. 2011. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. Journal of Physiology and Pharmacology, 62, 357.
Published
2019-12-05
How to Cite
hamadameen, B., and D. M. Hamad Ameen. “Synthesis, Characterization, and Antibacterial Activity of Novel Mutual Non-Steroidal Anti-Inflammatory Prodrugs”. ZANCO Journal of Pure and Applied Sciences, Vol. 31, no. 6, Dec. 2019, pp. 61-74, doi:10.21271/zjpas.31.6.7.
Section
Biology and Medical Researches